Neutrophils, unopposed neutrophil elastase, and alpha1-antiprotease defenses following human lung transplantation
Neutrophils, unopposed neutrophil elastase, and alpha1-antiprotease defenses following human lung transplantation
复制标题
DOI:
10.1164/ajrccm.164.1.2006096
复制
发表时间:
2001-07-01
影响因子:
24.7
通讯作者:
Love, RB
中科院分区:
文献类型:
--
作者:
Meyer, KC;Nunley, DR;Love, RB
Neutrophils are sequestered in the newly transplanted lung after reperfusion or with infection, rejection, and chronic graft dysfunction. Because unopposed (free) neutrophil elastase (NE) released into bronchoalveolar secretions may injure the lung allograft and impair bacterial clearance, we assessed total neutrophil numbers, myeloperoxidase activity as an index of neutrophil influx and degranulation, alpha(1)-antiprotease (alpha (1)-AP) concentrations, and unopposed NE activity in bronchoalveolar secretions from luna transplant recipients. Unopposed NE activity was present in bronchoalveolar lavage fluid (BALF) from recipients transplanted for emphysema associated with alpha (1)-AP deficiency as well as recipients without such deficiency (171 of 2,137 BALF; 8%). Ten of 17 (59%) recipients with alpha (1)-AP deficiency who were followed for at least 1 yr after transplant with multiple surveillance and diagnostic bronchoscopies had at least one BALF containing unopposed NE, usually associated with the presence of greater than or equal to 10(5) colony forming units/ml BALF of aerobic bacteria. In contrast, 19 of 58 (33%) with emphysema not associated with alpha (1)-AP deficiency, 8 of 32 (25%) recipients with cystic fibrosis (CF), 6 of 16 (38%) with idiopathic pulmonary fibrosis (IPF), and 11 of 36 (31%) with other indications for transplant had unopposed NE in BALF. alpha (1)-AP levels were significantly elevated in the early posttransplant time period and could be augmented considerably in alpha (1)-AP-deficient recipients with episodes of infection or rejection. Our findings indicate that unopposed NE activity can be found in both alpha (1)-AP-deficient and alpha (1)-AP-sufficient recipients after transplantation, usually in association with endobronchial bacterial infection.